2020
The evanescence and persistence of RBC alloantibodies in blood donors
Hauser RG, Esserman D, Karafin MS, Tan S, Balbuena‐Merle R, Spencer BR, Roubinian NH, Wu Y, Triulzi DJ, Kleinman S, Gottschall JL, Hendrickson JE, Tormey CA, ). The evanescence and persistence of RBC alloantibodies in blood donors. Transfusion 2020, 60: 831-839. PMID: 32061102, DOI: 10.1111/trf.15718.Peer-Reviewed Original ResearchMeSH KeywordsAdultAntibody SpecificityBlood DonorsErythrocytesFemaleHumansIsoantibodiesKineticsMaleMiddle AgedConceptsBlood donorsAntibody persistenceAntibody screenDonor Evaluation Study-IIIHistory of transfusionUS blood centersFit inclusion criteriaPresence of alloantibodiesRecipient EpidemiologyRBC alloantibodiesBlood productsInclusion criteriaSignificant antibodiesBiologic factorsHealthy populationAntibody detectionAntibody identificationAlloantibodiesBlood centersMultiple antibodiesFirst donationAntibody specificityStudy IIIAntibodiesCenter policies
2019
Red Blood Cell Alloimmunization in Pediatric Sickle Cell Disease Population of Puerto Rico: An Observational Study
Balbuena-Merle RI, Nazario-Delgado CM, Rosario-Rosado RV, Millán-Tapia D, Climent-Peris C. Red Blood Cell Alloimmunization in Pediatric Sickle Cell Disease Population of Puerto Rico: An Observational Study. Annals Of Laboratory Medicine 2019, 40: 187-189. PMID: 31650739, PMCID: PMC6822008, DOI: 10.3343/alm.2020.40.2.187.Peer-Reviewed Original ResearchRed blood cell alloimmunization is associated with lower expression of FcγR1 on monocyte subsets in patients with sickle cell disease
Balbuena‐Merle R, Curtis SA, Devine L, Gibb DR, Karafin MS, Luckey CJ, Tormey CA, Siddon AJ, Roberts JD, Hendrickson JE. Red blood cell alloimmunization is associated with lower expression of FcγR1 on monocyte subsets in patients with sickle cell disease. Transfusion 2019, 59: 3219-3227. PMID: 31355970, PMCID: PMC7075520, DOI: 10.1111/trf.15463.Peer-Reviewed Original ResearchConceptsSickle cell diseaseMonocyte subsetsTotal monocytesCell diseaseComplications of SCDRed blood cell alloimmunizationRed blood cell alloantibodiesElectronic medical recordsTransfusion exposureSerum cytokinesIntermediate monocytesRBC alloantibodiesInflammatory milieuCD64 expressionClassical monocytesPeripheral bloodInflammatory functionsMedical recordsAntibody formationClinical significancePatientsMonocytesFlow cytometryLow expressionRespondersRed blood cell alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease
Balbuena-Merle R, Hendrickson JE. Red blood cell alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease. Transfusion Clinique Et Biologique 2019, 26: 112-115. PMID: 30857806, DOI: 10.1016/j.tracli.2019.02.003.Peer-Reviewed Original ResearchConceptsHemolytic transfusion reactionsSickle cell diseaseRed blood cell alloimmunizationRBC alloantibodiesTransfusion reactionsRBC alloimmunizationCell diseaseLife-threatening hemolytic transfusion reactionsSubset of patientsBlood bank testingCurrent screening practicesAlternative complement pathwayRBC autoantibodiesTransfusion burdenInflammatory statusPatient populationCase reportRBC exposureBlood donorsScreening practicesHigh prevalenceChronic hemolysisAlloantibodiesBystander hemolysisPatients